The question of whether individuals should be allowed to develop their own marijuana in countries where it is legitimate has created disagreements between those who otherwise agree to a broad reform of cannabis, advocates working to expand access while some companies take up opposite position. The latest example comes from New Hampshire, where a lobbyist representing the Sanctuary ATC Medical Dispensary testifies this week against a bill that will allow patients and caregivers to cultivate cannabis.
But after the testimony was handed over to the Senate Human Services Committee on Tuesday, advocates sounded alarmed and CEO of the company said it was all a big misconception.
Lobbyist Michael McLaughlin claims to lawmakers that legislation will raise retail prices, raise health concerns and undermine New Hampshire's Regulatory System.
Many patients and legalization advocates consider home care as a major tool to be resolved in all countries where marijuana is legal. They think this is a matter of civil liberties and a way to offer access to those who can not afford retail prices.
But Sanctuary, based in Plymouth, New Hampshire, has not made a case when the lobbyist of the company has appeared before Legislators this week.
Instead, McLaughlin told members of the group that legislation, if ordered, would essentially constitute a violation of an agreement that the government had made with cannabis licensors who had invested significant capital in the medical cannabis program, that Patients could not afford to develop their own and therefore would have to spend their money in the dispensaries.
New Hampshire lawmakers approved medical marijuana in 201
we have a therapeutic program for cannabis, which is just under three years, and the economy of therapeutic cannabis centers. is dramatic and millions of dollars are invested, "McLaughlin said. "The whole contract between the people licensed in the state is immediately undermined by placing home-grown cannabis in the equation."
Although the witness raised other concerns about quality control and cannabis application standards, the financial issues received most emphasis. He argues that three years is not enough time to regain the investment needed to expand the company, and said drug prices would increase if the bill were passed.
"You will hear some pathetic stories from patients. but if you look at what the state has asked for from the three licensees, which is to invest millions and millions of dollars in a New Hampshire program, you are now saying to them, "Well, we changed our minds. "
But Sanctuary CEO Jason Sidman told Marijuana Moment that McLaughlin misrepresented the company's position and actually backed the legislation. He said there are some changes the company wants to see – especially with regard to certain definitions included in the bill – but has never heard of arguments that the lobbyist has made about the economic consequences of resolving home farming.
He also rejected. the idea that allowing patients and caregivers to raise cannabis would raise prices in dispensaries. "In the end, I believe the right of every patient is to make their own medicine if they choose," Sidman said. "I just think it should be – some of the definitions around this law really need to be clarified. And of course, this is our opinion again. "
" I wish I had been there yesterday, but all I can do now is just to move forward, clarify the position of the Sanctuary, and support the Cannabis Therapy Program and our patients best. To correct the record, Sidman said he planned to send a letter to the committee chairman and members to explain that Sanctuary did not oppose the legislation that was approved by the full parliament earlier this month. and to clarify what changes in the bill is supported by the company. "There may be some possible discrepancies between our thoughts about the HB 364, and I think that clarification will really make it clear," he said. Although it seems unusual for the lobby lobster to visit the legislature and issue written and verbal testimony without first having it held by the CEO, the alleged discrepancy may be ineffective for the advocates. Sidman's letter, which he announced by Thursday at the latest, may eventually strengthen efforts to turn into local legislation.
"The public testimony proposed on Tuesday by the sanctuary lobbyist in opposition to HB 364 was very offensive to patients who feel strongly about being allowed to grow their own plants," said Matt Simon, political director of New England in the "Marijuana Policy" project, Marijuana said. "However, Jason Sidman, Chief Executive of the Sanctuary, seems very sincere to help move HB 364."
"Because of the patients who can not afford to wait, I hope our efforts to convince the Senate will be successful this year, "he said." Caring for your own medical needs should not be a crime in the state "Live Free or Dead".
Marijuana approached McLaughlin for comment, but he did not respond until the time of publication.
Beyond this particular example, conflicts between advocates and the interests of the industry are intensifying. Legislators across the country see appeals to go beyond just legalizing a cannabis trade market and take steps to ensure that small businesses, people of color, women, and other communities affected by the ban are not left in dust as big companies assume power.
This is partly the reason why Marijuana's Mass Judge announced last month that a New York-based business association for medical marijuana defended domestic cultivation in a political statement filed in the office of Governor Andrew Kuomoto (D). The association, made up of large companies such as Vireo Health, Acreage, Columbia Care, and MedMen, does not directly indicate that their opposition is profitable, but defenders say the money is at the bottom of the recommendation not to let people grow their own marijuana.
In New Hampshire, although the bill allows home cannabis to grow through the legislature, lawmakers are also working to pass legislation to legalize adult marijuana after the full house, and then
You can read the home-grown testimony of the sanctuary lobbyist here:
Sanctuary ATC Trial of Marijuana for Scribd
Marijuana companies have called on the manager to ban cannabis cultivation, the submission of documents
With the courtesy of Mike Latimer.